Manufacture of other food products n.e.c.
THALASSO BIOTECH AS
Revenue 2024
NOK 264,000
Operating profit
NOK 186,000
Equity
NOK 30,000
Incorporated
2022
Share capital
NOK 100,000
Key figures · 2024
Current ratio
1.23
Equity ratio
18.9%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 70.7% | |
| Net margin (%%) | 69.7% | |
| Return on assets (%%) | 117.5% | |
| Likviditet | ||
| Current ratio | 1.23 | |
| Working capital | 30k | |
| Soliditet | ||
| Equity ratio (%%) | 18.9% | |
| Debt-to-equity ratio | 4.28 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.